Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $467.35, signifying a +1.35% move from its prior days close.…

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Heres Why

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $438.92, representing a -2.36% change from its previous close.…

Vertex Pharmaceuticals Aktie: Bernstein hebt auf Outperform - Top-Biotech-Pick für 2026

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Sanford C. Bernstein & Co:Der Analyst William Pickering von Bernstein hat die Aktie…

Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $463.86, indicating a -1.24% shift from the previous trading…

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Vertex Pharmaceuticals (VRTX) reached $469.68 at the closing of the latest trading day, reflecting a -2.99% change compared to its…

Vertex Pharmaceuticals: 2026/27 könnte zum Daten-Knall für die Aktie werden

Zürich (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse der UBS:UBS-Analyst Michael Yee habe die Coverage von Vertex Pharmaceuticals mit einer Kaufempfehlung ("buy"-Rating) und…

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $453.74, marking a -1.31% move from the previous day.…

Vertex Pharmaceuticals Aktie: Sorgt die Pipeline jetzt für den nächsten Schub?

Boston, MA (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Leerink Partners:Leerink habe das Kursziel für die Aktie von Vertex Pharmaceuticals Inc. (ISIN:…

Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $449.52, denoting a -1.2% move from the…

Vertex Pharmaceuticals Aktie: Bullishes Update nach Labortour und Analystenmeeting

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Morgan Stanley:Die Analysten von Morgan Stanley stufen die Aktie von Vertex Pharmaceuticals Inc.…

Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?

The stock has fallen from a peak back in April.…

Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

Vertex (VRTX) delivered earnings and revenue surprises of +5.49% and +1.14%, respectively, for the quarter ended September 2025. Do the…

Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $417.21, denoting a -1.23% move from the…

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030

Vertex appears to be by far the better buy right now.…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $416.81, representing a +2.01% change from its previous close.…

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $407.9, denoting a -1.05% move from the…

Heres Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $414.86, representing a -1.49% change from its previous close.…

Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $403.3, indicating a -1.36% shift from the previous trading…

Vertex Pharmaceuticals Aktie: Die Schere zwischen Nasdaq Biotech und der Aktie geht weit auseinander

Paris (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von der BNP Paribas:Egmond Haidt, Analyst der BNP Paribas, nimmt die Aktie von Vertex Pharmaceuticals…

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $408.85, representing a +1.15% change from its previous close.…

Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $385.74, indicating a +1.01% shift from the previous trading…

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $381.87, denoting a +1.39% move from the…

Vertex Pharmaceuticals Aktie: Truist bleibt bei "buy" - doch warum sinkt das Kursziel_

Bad Marienberg (www.aktiencheck.de) - Truist bleibt bullish auf Vertex Pharmaceuticals – trotz Kurszielsenkung Ein neues Kapitel in der spannenden Geschichte von…

Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates

Vertex (VRTX) delivered earnings and revenue surprises of +6.60% and +2.59%, respectively, for the quarter ended June 2025. Do the…

Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more

These are the stocks posting the largest moves in extended trading.…

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Vertex Pharmaceuticals (VRTX) closed at $468.41 in the latest trading session, marking a +1.64% move from the prior day.…

brite(TM)-Plattform von XO Life: Digitale Therapiebegleitung für Menschen mit Mukoviszidose

XO Life GmbH: München (ots) - Vertex Pharmaceuticals, ein US-amerikanisches Pharmaunternehmen mit Fokus auf schwere Erkrankungen wie Mukoviszidose, Beta-Thalassämie und…

Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $476.95, signifying a +1.45% move from its prior days close.…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $470.13, denoting a +2.54% move from the…

3 Monster Stocks in the Making to Buy Right Now

Key PointsCRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential remaining.Viking Therapeutics is targeting…

3 Top Growth Stocks to Buy in the Second Half of 2025

Key PointsAlibaba is a Chinese AI stock thats dirt cheap.Meta Platforms is making a huge bet on AI that should…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed at $469.55 in the latest trading session, marking a +1.15% move from the prior day.…

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

Vertex Pharmaceuticals (VRTX) reached $464.2 at the closing of the latest trading day, reflecting a -1.73% change compared to its…

The Best Stocks to Invest $1,000 in Right Now

Alibaba offers an inexpensive way to invest in AI. Amazon has multiple growth opportunities, including AI, robotics, e-commerce, and…

Motley Fool Co-Founder David Gardner Reviews Stock Picks

Were approaching the 10-year anniversary of the first of Rule Breaker Investings 30 five-stock samplers, picked from 2015 to 2021.…

Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz

Key PointsProKidney announced results of a Phase 2 clinical trial.The stock, which was less than $1 per share, skyrocketed on…

3 No-Brainer Stocks to Buy in July

Key PointsAbbVie offers something for every investor.Eli Lilly could be overdue for a big rally.Vertex Pharmaceuticals is in a new…

The Best Stocks to Invest $1,000 In Right Now

Key PointsAlibaba offers a cheap way to invest in artificial intelligence (AI), cloud computing, digital media, and e-commerce.UnitedHealth Group is…

2 Beaten-Down Stocks With Massive Upside Potential

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues…

Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts

Vertex Pharmaceuticals (VRTX) reached $452.16 at the closing of the latest trading day, reflecting a +1.56% change compared to its…

Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?

Investors looking for stocks that can produce dramatic gains in a short amount of time will want to turn their…

Heres Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $440.87, denoting a -1.68% move from the…

2 Growth Stocks to Buy and Hold for 10 Years

Popular themes on Wall Street today include artificial intelligence (AI), the market for weight management medicines, and the potential impact…

Vertex Pharmaceuticals Aktie: CF-Launch bleibt hinter Erwartungen - RBC senkt Kursziel auf 420 USD

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Der Analyst Brian Abrahams von RBC Capital Markets hat das Kursziel für…

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Youre unlikely to have a warm-and-fuzzy feeling after buying some stocks. Instead, some stocks can keep you awake at night…

Vertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should Know

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $455.45, denoting a -1% move from the…

The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip

Even though broader equities have been highly volatile this year, its still a good idea to invest in stocks for…

3 No-Brainer Healthcare Stocks to Buy in June

A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe…